IF by specialty › Hematology
Blood Advances — Impact Factor
The 2025 Impact Factor of Blood Advances is 7.7 (Q1 in Hematology; fully open access).
- Impact Factor
- 7.7 JCR 2025
- JCR category
- Hematology
- Quartile
- Q1 in Hematology
- Publisher
- American Society of Hematology
- Open access
- fully open access
- IF source
- ashpublications.org
Position within the field
Ranked 13 of the 38 journals in Hematology on this site (top 50%).
Hematology journals with a similar Impact Factor
- American Journal of Hematology IF 9.4
- Arteriosclerosis, Thrombosis, and Vascular Biology IF 8.8
- Leukemia IF 8.8
- Haematologica IF 8.2
- Blood Reviews IF 7.2
- Critical Reviews in Oncology/Hematology IF 6.2
About this value
The Journal Impact Factor of Blood Advances (JCR 2025, released June 2026) is 7.7. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Hematology.